SK hynix Inc. SKHY

Full chart Compare
Set alert

Price alert · SKHY

All alert types
150.79 USD +3.08 (+2.09%)

At closeNov 3, 2026, 6:45 PM EST

153.30 +2.51 +1.66%

After hours · Nov 3, 6:45 PM ET

149.79 Day range 154.05
124.80 52-week range 199.87
YTD
-10.25%
1 year
-10.25%

Discussion (47)

Sign in to join the discussion

James Thursfield SKHY 1 week ago #1

$SKHY. Buying more tomorrow. This is stupidly cheap. The fundamentals and growth profile is way too strong for it to be sitting down at these levels.

Inertia and mars have fun taxpayers SKHY 1 week ago #2

$SKHY. Beyond absurd forward p/e of 3.. this tech market is beyond oversold. The model that is generating a selloff is based on socialism in the USA. The net impact is zero, the tax laws are so hard to understand that the tax measures are poorly written nothing ever gets passed… massive buying opportunity

bo luc SKHY 2 weeks ago #3

From 198 to 140 in 2 weeks

Member SKHY 4 weeks ago #5

It’ll be up 10$ tomorrow all this hoopla for nothing just options scenarios

Member SKHY 1 month ago #6

This whole market is a scam the big boys sell from one fund so the other fund in the same family can buy it at a lower price so they can cash in their shorts wash rinse repeat $$$&&&???

Member SKHY 1 month ago #7

Something is cooking huge volume $$$????!!!🙂

Zeev Bovan SKHY 1 month ago #8

Bank of America Corp DE Buys 430,014 Shares of Protara Therapeutics, Inc. $TARA
Defense World StaffAug 29th, 2026
Protara Therapeutics logoBank of America Corp DE grew its stake in shares of Protara Therapeutics, Inc. (NASDAQ:TARA – Free Report) by 86.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 925,918 shares of the company’s stock after buying an additional 430,014 shares during the period. Bank of America Corp DE owned approximately 1.65% of Protara Therapeutics worth $4,824,000 as of its most recent filing with the Securities and Exchange Commission.

Almighty SKHY 1 month ago #9

There is a zero chance to slow down AI research, the market is overreacting as usual